 
| Course: |
Internal Medicine 1422
|
| Target Audience: |
| This activity is intended for the internist and family practitioner. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue. |
| Faculty |
Executive Editor
Stephen A. Brunton, MD
Clinical Professor
University of California, Irvine
Associate Editors
Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California
Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine
Barbara A. Phillips, MD, MSPH
Professor of Medicine,
University of Kentucky;
Director, Sleep Disorders
Center,
Samaritan Hospital,
Lexington
William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA
Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY |
| Subjects: |
- Lifetime Follow-up Care after Childhood Cancer
- Is It a Coincidence that Death Rhymes with Breath?
- Should Everyone Be on Fish Oils?
- Dabigatran Etexilate mesylate Capsules (Pradaxa®)
- Clinical Briefs
|
| Objectives: |
- describe new findings in differential diagnosis and treatment of various diseases
- describe controversies, advantages, and disadvantages of those advances
- describe cost-effective treatment regimens
- describe the pros and cons of new screening procedures.
|
| Financial Disclosure: |
Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Amylin, Novo Nordisk, Shionogi Pharma, and Takeda; he receives grant/ research support and and serves on the speakers bureaus of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Mary Elina Ferris, MD, Harold L. Karpman, MD, FACC, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Barbara A. Phillips, MD, MSPH is a consultant for Cephalon, and serves on the speakers bureaus for Resmed and Respironics. Associate editor Louis Kuritzky, MDis a consultant for Abbott, AstraZeneca, Boehringer Ingelheim, Daiichi, Sankyo, Forest Pharmaceuticals, Lilly, Novo Nordisk, Takeda.
Copyright 2010 AHC Media. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
